Abstract Cardiovascular disease (CVD) remains the leading cause of maternal mortality, and clinical diagnosis of CVD in women during pregnancy is challenging. Pregnant women with known heart disease require careful multidisciplinary management by obstetric and medical teams to assess for maternal and fetal risk.
Introduction
Maternal cardiac disease complicates approximately 0.2 to 4 % of pregnancies at present, which is a major cause of non-obstetric morbidity [1•] . The number of pregnant women who develop cardiac problems is becoming more prevalent than before as women are increasingly seeking pregnancy at a later age [2] . Echocardiography is, by far, the preferred diagnostic test for cardiac disease in pregnant women for its safely and general availability with no risk of radiation to the mother and the fetus. Echocardiography provides precise information about structural abnormalities and illuminates the pathophysiology of cardiac disease and its hemodynamic consequences. In addition, echocardiography helps in determining whether intervention should be performed prior to or during pregnancy or if the severity of cardiac condition deems pregnancy very high risk and, hence, contraindicated.
Physiologic Alterations During Pregnancy
Significant cardiovascular hemodynamic changes occur during pregnancy. These physiologic alterations in the cardiovascular system mimic cardiac disease, making clinical diagnosis of heart disease challenging. Cardiac output increases by
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approximately 50 % at the early to mid-third trimester and is maintained until term. While increased preload and stroke volume contribute to the increased cardiac output during the first trimester, the increased heart rate accounts for the increased cardiac output in the second trimester [3] . Increases in hormonally mediated blood volume and red cells also lead to a major increase in cardiac output in pregnancy [4] . During labor, pain and uterine contractions also produce increases in cardiac output and blood pressure during labor and delivery. Furthermore, relief of caval compression and auto-transfusion from the emptied and contracted uterus immediately after delivery results in a further increase in cardiac output. Peripheral vascular resistance decreases during pregnancy. The mean arterial pressure decreases about 10-15 mmHg to accommodate the increased cardiac output and preserve the efficiency of ventricular-arterial coupling and diastolic perfusion pressure at the end of the second trimester [5•] . These hemodynamic changes often resolve by 2 weeks postpartum [6] .
Echocardiographic Findings in Normal Pregnancy
The echocardiographic changes during pregnancy summarized in Table 1 are based on the physiologic alterations as mentioned above. The increased blood volume and cardiac output during pregnancy lead to dilation of the heart; the left ventricular (LV) end-diastolic dimension increases slightly but remains within normal limits in normal pregnancy. A reversible Bphysiologic^LV hypertrophy also exists during pregnancy. The LV mass increases resulting from the increased LV diameter and increased LV posterior wall and intraventricular septal thickness. Similar to the LV, the right ventricle (RV) increases in size over the course of pregnancy because of increased preload [8, 9] .
There is discrepancy among studies as to whether LV contractility increases in pregnancy. Most studies have found no significant change in ejection fraction [5•, 6, 10, 11] . Some have found a decrease in the ratio of wall stress to velocity of circumferential fiber contraction, implying enhanced intrinsic myocardial contractility [11] , whereas others have concluded that ejection fraction or contractility as measured by fractional shortening and velocity of circumferential fiber contraction decline slightly, especially in the late third trimester [12] [13] [14] . We found a slight decrease in LV ejection fraction in the third trimester using 3D echocardiography [15] . Others have shown a decrease in longitudinal LV shortening, as measured by longitudinal tissue Doppler strain, toward the end of pregnancy, and an increase in LV globularity [16] . However, our own observations using speckle tracking strain rate indicate an increase in cardiac contractility as demonstrated by an increase in LV radial and longitudinal rate of deformation, particularly during first and second trimesters [17] . Savu and colleagues [9] also observed increased LV and RV longitudinal strain rate in the first trimester. These discrepancies reported in strain/ strain rate appear related to the load dependency of these measurements along with differences in imaging techniques. The tethering effect of neighboring segments influences tissue Doppler imaging measurements [18] . In contrast, speckle tracking is a 2D technique not subject to the angle dependency of Doppler and of motion of surrounding segments.
There have been conflicting reports regarding changes in diastolic function during pregnancy. Because of substantial alterations in the heart rate and contractility, preload and afterload, LV mass, and volume in pregnancy, assessment of LV diastolic function requires a combination of loaddependent and load-independent parameters. Most studies show that LV diastolic function is preserved in normal pregnancy, although the preload is increased [19, 20] . The peak [7] ; copyright Elsevier LVOT left ventricular outflow tract, TR tricuspid regurgitation, VTI velocity-time integral early and late diastolic mitral inflow (E wave and A wave) velocities increase resulting from increased preload and blood volume. However, the change in the A wave is greater than E wave; therefore, a decreased E/A ratio is found in normal pregnancy that may be caused by the enhanced atrial contraction forced by increased left atrial filling pressures [21] . Similarly, the early and late diastolic myocardial velocity ratio (E'/A') also decreases because of increased atrial contractility [20] . However, the E/E', which is a validated marker of left atrial pressure, does not change beyond normal range. The normalization of mitral flow occurs around 2 months after childbirth [4] .
The left atrium serves as a reservoir, a conduit, and a booster pump during the cardiac cycle [22] . The atrial size increases gradually in pregnancy, although the measurement still remains within normal limits [23] . Song et al. evaluated left atrial function using speckle tracking echocardiography in pregnancy and found that the left atrial reservoir and booster pump function is increased. The conduit function is decreased, which may be caused by the physiological myocardial hypertrophy during pregnancy. However, the changes are reversible [24] .
Few echocardiographic studies have evaluated RV function during pregnancy. Savu and associates using tissue Doppler strain rate imaging of the RV free wall [9] found an increase in RV longitudinal strain rate in the first and second trimesters and a decrease in the third trimester indicating an increase in RV contractility during early and mid pregnancy.
Other normal cardiac structural changes that can be shown by echocardiography include an increase in aortic root, mitral, and tricuspid annular size; and an increase in stroke volume leading to an increase in Doppler flow velocity across the aortic valve. Mild valvular regurgitation occurs normally in pregnancy and has been demonstrated in up to 28, 94, and 94 % of mitral, tricuspid, and pulmonic valves [25•] .
Asymptomatic pericardial effusions occur in approximately 40 % of pregnant women, and effusions become more common in the third trimester and in women who gain more than 12-kg weight, suggesting that increased fluid retention may play an important role in the development of effusion [26] . Pericardial effusion was reported to be completely resolved in all patients on repeat echocardiograms done at 6 weeks after delivery [26] .
Peripartum Cardiomyopathy
The European Society of Cardiology (ESC) Working Group defined peripartum cardiomyopathy (PPCM) as a form of dilated cardiomyopathy which presents with heart failure signs in the last month of pregnancy or within 5 months postpartum [27] . In this classification, the diagnosis is made in the absence of other abnormal loading conditions such as hypertension, valvular heart diseases, or coronary disease. In 2010, the heart failure association of ESC Working Group expanded the definition as follows: BPeripartum cardiomyopathy is an idiopathic cardiomyopathy presenting with heart failure secondary to LV systolic dysfunction towards the end of pregnancy or in the months following delivery, where no other cause of heart failure is found. It is a diagnosis of exclusion. The LV may not be dilated but the LVEF is nearly always reduced below 45 %^ [28] .
PPCM is a disease with high morbidity and mortality, and the true prevalence and etiology are unknown because of few population-based studies in PPCM. The pathophysiology is unclear, and coincidental presence of multiple factors such as inflammation, impaired vasculature, and oxidative stress in previously healthy women has been blamed. Many researchers consider pregnancy-induced hypertension as a risk factor for PPCM [29, 30] ; however, hypertensive heart failure of pregnancy was defined as the occurrence of peripartum heart failure related to any form of hypertension. A recent study focused on the differentiation between PPCM and hypertensive heart failure of pregnancy showed that LV diastolic and systolic dimensions are larger, while the left ventricular ejection fraction (LVEF) and LV fractional shortening are lower, in PPCM patients [31] .
The diagnosis of PPCM requires exclusion of other causes of cardiomyopathy and the confirmation of reduced LV systolic function and/or LV dilation, usually by echocardiography [28] . Video 1 shows the decreased wall motion in a patient with PPCM. LV mural thrombi can sometimes be visualized [32] . Additionally, echocardiography can predict the prognosis in PPCM. The early recovery was 6.4-fold higher in patients with an LVEF ≥30 % upon presentation than in the patients with an LVEF of 10-19 % [33] . Figure 1 shows echocardiographic findings of PPCM in a 31-year-old female with an LVEF of 25 % and peak longitudinal speckle tracking strain of -9.0 % (normal is more negative than -18 %).
LV contraction involves longitudinal, radial, and circumferential shortening. The longitudinally directed fibers mainly situated in the subepicardium and subendocardium of the LV and RV free walls play a dominant role in maintaining normal ejection fraction and determining atrioventricular interaction [34] . When ventricular size is increased, the longitudinal fiber contraction is always reduced in addition to the reduced ejection fraction. Besides longitudinal strain, this longitudinal contraction can also be assessed by mitral or tricuspid systolic annular plane excursion [35] , providing a simple method to evaluate LV and RV function.
A recent study used tricuspid annular plane systolic excursion (TAPSE) to compare RV systolic function in patients with PPCM and idiopathic dilated cardiomyopathy (DCM) and found that the mean TAPSE was significantly less in PPCM (12.58 ± 4.27 vs 14.46 ± 3.21 mm, P < 0.028), suggesting that the RV systolic function in PPCM was worse [34] . Ventricular long-axis function can also be assessed using tissue Doppler that is able to detect LV dysfunction earlier than conventional 2D and Doppler measures [36] . Speckle tracking imaging is a two-dimensional method and more robust than tissue Doppler to assess LV and RV function. However, it has not been evaluated in PPCM.
Acquired Valvular Heart Disease
Rheumatic heart disease is the most common acquired valve disease present during pregnancy and accounts for up to 90 % of valve disease during pregnancy worldwide. Maternal and fetal risks in patients with valvular disease correlate with the type and severity of the valve lesion, LV function, pulmonary artery pressure, and functional capacity ( Table 2) . A recent study reported that mitral valve disease including mitral stenosis and/or regurgitation accounts for 63 % and the aortic valve disease for another 23 % [37] .
Mitral Valve Stenosis
Rheumatic mitral stenosis (MS) is the most common valve disease during pregnancy. The patient may be asymptomatic until the hemodynamic changes associated with pregnancy unmask its presence. The 2014 AHA/ACC guidelines for valvular heart disease define severity of mitral valve stenosis as follows: mitral valve area (MVA) >2.0 cm 2 = mild, 1.6-2.0 cm 2 = moderate, and ≤1.5 cm 2 = severe, along with diastolic pressure half-time ≥150 ms (diastolic pressure half-time ≥220 ms with very severe MS), severe left atrial enlargement, and pulmonary artery systolic pressure >30 mmHg [38] . Mild MS is associated with much less morbidity, while moderate and severe stenoses are associated with increased rates of adverse events. The normal cardiovascular changes of pregnancy, superimposed on the stenotic mitral valve with restricted flow from the left atrium to the LV, worsen maternal and perinatal complications. Because the flow across the valve is essentially fixed, the progressively increased preload with advancing gestation leads to an increase in the pressure gradient from the left atrium to the LV. The elevated left atrial pressure may lead to pulmonary edema or pulmonary hypertension in extreme cases. Arrhythmias such as atrial fibrillation may result from the chronically elevated left atrial pressure. Women with MS should be diagnosed and evaluated prior to conception by a multidisciplinary team; however, oftentimes, both patient and the physician are unaware of underlying valve disease until symptoms prompt echocardiography during pregnancy [39] .
The physiologic hypervolemia and increased heart rate can significantly increase the transmitral pressure gradient, which may lead to an overestimate of MS severity. The Doppler pressure half-time method (MVA = 220/pressure half-time) may overestimate valve areas in pregnancy and may lead to life-threatening consequences. The continuity equation, which is calculated as stroke volume / transmitral velocity time integral, appears to be a valid method for estimating MVA during pregnancy [40] . Planimetry has been shown to have the best correlation with anatomic MVA as assessed by explanted valves [41] . However, it tends to overestimate MVA compared with 3D TEE measurements, especially in patients with a large left atrium [42] . Mitral valve gradient is a hemodynamic factor of substantial prognostic value in patients with acquired mitral valve disease [43] . Figure 2 shows echocardiographic findings of severe rheumatic MS in a pregnant woman; video 2 and video 3 demonstrate severe mitral stenosis in the short-axis view and the turbulent diastolic color Doppler of mitral valve stenosis in the same patient.
The severity of MS correlates with the incidence of maternal complications. Pulmonary edema occurred in approximately 60 % of patients with significant MS at the gestational age of 30 weeks, when the vascular volume is near its peak, and in 20 % of these patients occurred in the presence of atrial tachyarrhythmias [44] . Supraventricular tachycardias and atrial fibrillation, especially with a rapid ventricular response, can lead to reduced ventricular diastolic filling and cardiac output [25•] , as well as left atrial appendage thrombus with a risk of embolization.
Percutaneous mitral balloon valvuloplasty can be performed without significant maternal or fetal risk during pregnancy and has been used as a viable option for the treatment of pregnant women with severe mitral valve stenosis [45] . An echocardiographic score in MS including valvular thickness, mobility, calcification, and subvalvular disease is relatively important, with a score of ≤8 predicting a more successful outcome [46] . In addition, transthoracic echocardiography also can be used to diagnose concomitant mitral regurgitation, subvalvular stenosis, and left atrial thrombi. Transesophageal echocardiography also has been established as a diagnostic and safe option in pregnant women, especially for evaluation of mitral valve anatomy and for the detection of left atrial thrombus prior to consideration for balloon valvuloplasty during or after pregnancy [47] .
Mitral Valve Insufficiency
Mitral valve insufficiency accounts for the second most frequent valve disease during pregnancy. Mitral valve prolapse from myxomatous mitral valve disease is the most common etiology in the developed world. Mitral valve insufficiency can also result from rheumatic heart disease, ischemic heart disease, and rupture of chordae tendineae. Although an increase in the overall blood volume leads to an increase in mitral valve insufficiency, the reduced systemic resistance and systolic blood pressure may lead to a decrease in the regurgitation , mean gradient <5 mmHg) without severe pulmonary HTN Mild/moderate PS AR aortic valve regurgitation, LV left ventricle, MS mitral valve stenosis, AS aortic valve stenosis, PS pulmonic stenosis, MV mitral valve, MR mitral valve regurgitation, LVEF left ventricular ejection fraction during pregnancy [43] . Therefore, patients often tolerate mitral regurgitation well-although severe mitral regurgitation with increased end-diastolic pressure may lead to heart failure [48] . Echocardiography should be used to assess the etiology of regurgitation, as well as ventricular function, especially for those who develop acute regurgitation and decompensation [43] .
Aortic Valve Stenosis
The incidence of aortic valve stenosis is 0.5-3 % in pregnancy with heart valve diseases [47] [48] [49] [50] . The most common etiologies are congenital bicuspid aortic valve and rheumatic heart disease. Figure 3 shows severe rheumatic aortic valve stenosis in the same patient as in Fig. 2 , who also had severe rheumatic mitral valve stenosis. Similar to MS, mild-to-moderate aortic stenosis with normal ventricular function is often well tolerated, while severe aortic stenosis is poorly tolerated during pregnancy. The severe complications of aortic stenosis including angina, syncope, and congestive heart failure necessitate prompt evaluation. A significant increase in pressure gradient can be found due to hypervolemia, increased heart rate, and increased cardiac output during pregnancy. There may be associated LV hypertrophy. Despite increased demand in pregnancy, the cardiac output is fixed in severe aortic stenosis. Similar to mitral valve stenosis, an increased preload can lead to elevation in left atrial and pulmonary artery pressures. However, decreased preload can cause life-threatening underperfusion to the coronary arteries and the brain in patients with severe aortic stenosis. Echocardiography can measure the aortic valve area and pressure gradient, in addition to determining the severity of LV hypertrophy and systolic dysfunction; video 4 is transesophageal short-axis view at the mid-esophageal level showing stenotic aortic valve. A 
Aortic Valve Insufficiency
Similar to mitral valve insufficiency, aortic valve regurgitation is well tolerated in pregnancy, except in severe cases. As aortic valve regurgitation results in a fraction of stroke volume being directed back to the LV in diastole, long-standing aortic valve regurgitation may cause LV dilation and dysfunction. Echocardiography can assess the severity of aortic regurgitation, LV size, and ejection fraction.
Pulmonic and Tricuspid Stenosis and Regurgitation
Since pulmonary vascular resistance is low at baseline, pulmonic and tricuspid stenosis and regurgitation are generally well tolerated in pregnancy. As severe lesions are usually corrected in childhood, the presence of severe pulmonary and tricuspid valve disease in adulthood is rare. Besides congenital lesions, the etiology of pulmonary and tricuspid lesions also includes endocarditis from intravenous drug use. Echocardiography can determine the tricuspid valve function, size, severity of pulmonary stenosis, and regurgitation, as well as right ventricular enlargement/hypertrophy.
Pulmonary Hypertension
Primary and secondary pulmonary hypertensions have been often associated with approximately 30 and 50 % maternal mortality, respectively, despite improvement in medical therapy over the past decade [49, 50, 51•, 52] . Since most maternal deaths take place in the first month after delivery, recognition of pulmonary hypertension is essential in pregnant women. Echocardiography plays an important role in defining the etiology and the degree of pulmonary hypertension. Although the blood volume increases, the pulmonary vascular resistance decreases simultaneously and the mean pulmonary artery pressure should be <25 mmHg at rest in pregnancy. A pulmonary arterial systolic pressure of 50 mmHg or greater than two thirds the systemic pressure is considered high risk during pregnancy.
Coronary Heart Disease
Coronary heart disease is relatively uncommon in premenopausal women. However, it is one of the most common cardiac causes of maternal death, as cardiac disease is a leading cause of maternal mortality over the past two decades [51•, 52-54] . While symptoms such as epigastric pain and vomiting or dizziness related to coronary heart disease are atypical in pregnancy, the diagnosis can be delayed-especially in those without known heart disease. The diagnosis of coronary heart disease in pregnancy is based on ischemic symptoms, electrocardiographic findings, and elevations in cardiac biomarkers, with many of the same criteria as outside of pregnancy [55] . A normal echocardiogram does not exclude myocardial infarction, especially non-ST elevation myocardial infarction, during pregnancy.
Stress echocardiography has been recognized as a relatively accurate noninvasive test for diagnosing coronary heart disease. Exercise echocardiography has been shown to be safe in late gestation [54] [55] [56] [57] . If stress testing is required in pregnancy, exercise echocardiography is preferred because of no exposure to radiation or radiopharmaceutical agents [58] . Although there is no evidence that dobutamine stress echocardiography is unsafe in pregnant women who are unable to exercise, the European guidelines on the management of cardiovascular diseases in pregnancy state that dobutamine stress echocardiography should be avoided whenever possible [1•] .
Conclusions
The cardiovascular hemodynamic and physiologic changes of pregnancy are reversible. While the normal cardiovascular system is able to adapt to the increased requirements of pregn a n c y, t h e d i s e a s e d h e a r t m a y d e c o m p e n s a t e . Echocardiography can define the extent and severity of cardiac lesions and evaluate ventricular function as well as valvular abnormalities. Patients with established heart pathology should be thoroughly assessed prior to becoming pregnant.
Serial echocardiography and follow-up with a team of specialists throughout gestation are strongly recommended.
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